An Adrenalectomy Mouse Model Reflecting Clinical Features for Chronic Fatigue Syndrome.
Lee, Jin-Seok, Jeon, Yoo-Jin, Park, Samuel-Young et al. · Biomolecules · 2020 · DOI
Quick Summary
Researchers tested three different mouse models to find the best one for studying ME/CFS. They found that removing the adrenal glands (small organs that produce stress hormones) in mice created fatigue and pain symptoms most similar to ME/CFS, while other common models mainly produced depression-like behaviors. The adrenal-removed mice also showed specific brain changes involving inflammation and stress hormone pathways.
Why It Matters
Finding an appropriate animal model is critical for understanding ME/CFS mechanisms and testing potential treatments. This study suggests the neuroendocrine system—particularly adrenal dysfunction—may be central to ME/CFS pathology, potentially explaining why existing models focused on immune activation fall short. This could redirect research toward investigating hormone dysregulation as a therapeutic target.
Observed Findings
ADX mice exhibited fatigue-like behavioral performance and heightened pain sensitivity, unlike LPS/poly I:C mice which showed primarily depressive behaviors.
Astrocytes and TGF-β1 were particularly activated across all brain regions in ADX mice.
LPS injection activated microglia and 5-HT1A receptors in prefrontal cortex and hippocampus.
Poly I:C injection reduced serotonin levels while increasing 5-HT transporter and 5-HT1A receptor expression.
Inferred Conclusions
Bilateral adrenalectomy better reflects clinical ME/CFS features than conventional LPS or poly I:C models.
Neuroendocrine dysfunction and glial (astrocyte) activation, rather than primary neuroinflammation, may be more representative of CFS pathophysiology.
TGF-β1 signaling in astrocytes may be a key mechanism underlying ME/CFS-like symptoms.
Remaining Questions
Does adrenal hormone replacement reverse fatigue symptoms in the ADX model, and would this translate to therapeutic benefit in ME/CFS patients?
How do sex differences and chronic versus acute adrenalectomy affect model phenotypes and brain pathology?
What is the mechanistic relationship between adrenal insufficiency and astrocyte/TGF-β1 activation—is this direct or mediated through other systems?
What This Study Does Not Prove
This study does not prove that adrenal gland removal causes human ME/CFS or that adrenal insufficiency is the primary cause in patients. Animal models approximate but do not perfectly replicate human disease. The findings are correlational and do not establish whether astrocyte activation and TGF-β changes are drivers of fatigue or secondary consequences.